Y. Tratsiakovich

发表

The importance of nitric oxide availability in myocardial ischemia-reperfusion injury : regulatory roles of arginase, L-arginine and tetrahydrobiopterin

Y. Tratsiakovich, 2016 .

The Role of Arginase and Rho Kinase in Cardioprotection from Remote Ischemic Perconditioning in Non-Diabetic and Diabetic Rat In Vivo

D. Andersson, J. Lanner, J. Pernow, 2014, PloS one.

Erythrocytes From Patients With Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I.

C. Östenson, D. Andersson, U. Hedin, 2018, Journal of the American College of Cardiology.

Red Blood Cells in Type 2 Diabetes Impair Cardiac Post-Ischemic Recovery Through an Arginase-Dependent Modulation of Nitric Oxide Synthase and Reactive Oxygen Species

S. Catrina, K. Brismar, J. Lundberg, 2018, JACC. Basic to translational science.

Tissue‐specific up‐regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus

B. Climént, J. Pernow, A. Kiss, 2015, British journal of pharmacology.

Arginase inhibition reduces infarct size via nitric oxide, protein kinase C epsilon and mitochondrial ATP-dependent K+ channels.

A. Krook, J. Pernow, P. Sjöquist, 2013, European journal of pharmacology.

Downregulation of Erythrocyte miR-210 Induces Endothelial Dysfunction in Type 2 Diabetes.

U. Hedin, S. Catrina, L. Maegdefessel, 2021, Diabetes.

Inhibition of Rho kinase protects from ischaemia–reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes

J. Pernow, A. Kiss, P. Sjöquist, 2017, Diabetes & vascular disease research.

Arginase 1 is upregulated at admission in patients with ST‐elevation myocardial infarction

A. Gabrielsen, P. Eriksson, L. Folkersen, 2021, Journal of internal medicine.

Arginase as a target for treatment of myocardial ischemia-reperfusion injury.

J. Pernow, P. Sjöquist, Y. Tratsiakovich, 2013, European journal of pharmacology.

Myocardial protection by co-administration of L-arginine and tetrahydrobiopterin during ischemia and reperfusion.

K. Channon, P. Tornvall, J. Pernow, 2013, International journal of cardiology.

Erythrocytes Induce Endothelial Injury in Type 2 Diabetes Through Alteration of Vascular Purinergic Signaling

J. Pernow, M. Alvarsson, Y. Tratsiakovich, 2020, Frontiers in Pharmacology.

Altered Purinergic Receptor Sensitivity in Type 2 Diabetes-Associated Endothelial Dysfunction and Up4A-Mediated Vascular Contraction

C. Östenson, J. Pernow, Y. Tratsiakovich, 2018, International journal of molecular sciences.

Vagal nerve stimulation reduces infarct size via a mechanism involving the alpha‐7 nicotinic acetylcholine receptor and downregulation of cardiac and vascular arginase

J. Pernow, A. Kiss, Y. Tratsiakovich, 2017, Acta physiologica.

Therapeutic Potential of Sunitinib in Ameliorating Endothelial Dysfunction in Type 2 Diabetic Rats

C. Östenson, A. Danser, J. Pernow, 2021, Pharmacology.

Hypoxic erythrocytes mediate cardioprotection through activation of soluble guanylate cyclase and release of cyclic GMP

S. Catrina, E. Weitzberg, J. Lundberg, 2023, The Journal of clinical investigation.

mediate cardioprotection through activation of soluble guanylate

S. Catrina, E. Weitzberg, M. Carlström, 2022 .

Stimulation of Erythrocyte Soluble Guanylyl Cyclase Induces cGMP Export and Cardioprotection in Type 2 Diabetes

J. Lundberg, J. Pernow, M. Alvarsson, 2023, JACC. Basic to translational science.